Anti-SARS-CoV-1 and −2 nanobody engineering towards avidity-inspired therapeutics
Eugene M. Obeng, Christian K. O. Dzuvor, Michael K. Danquah
Topics & Concepts
AviditySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakNanotechnologyBiologyMedicineAntibodyMaterials scienceImmunologyInfectious disease (medical specialty)PathologyOutbreakDiseaseMonoclonal and Polyclonal Antibodies ResearchAdvanced biosensing and bioanalysis techniquesBacteriophages and microbial interactions